KRT88P and infection: In 2019 Kenya achieved an average coverage of 91% of 3rd dose HBV childhood vaccination [58], but in future studies, screening children for HBsAg, anti-HBc and anti-HBs by birth cohort would be important to determine the impact of the vaccine campaign on infection, exposure and immunity, and to identify any populations being missed by vaccine coverage.